Market Update: FOMC 50bp Rise, JPOW, KYMR, Musk, TWTR, TSLA | Dec 15

By Kirsteen Mackay

Share:

In this article

  • Loading...
  • Want to see what you should be buying? Check out our top picks.

In today's market update, we look at the FOMC's 50 basis point interest rate decision and news from Kymera Therapeutics, Delta Air Lines and Elon Musk.

Market Update: FOMC 50bp Rise, JPOW, KYMR, Musk, TWTR, TSLA | Dec 15
Market Update: FOMC 50bp Rise, JPOW, KYMR, Musk, TWTR, TSLA | Dec 15

US equity futures are flat, while bonds are mixed following the Federal Open Market Committee's (FOMC) decision to raise interest rates by 50 basis points, as expected.

The focus of the market's reaction is on the FOMC's peak rate projection, which came in higher than markets were pricing in. Chair Powell also pushed back against a dovish pivot by reiterating the "higher-for-longer" messaging and saying there would need to be "substantial evidence" that inflation is retreating sustainably before weighing cuts. However, the futures markets continue to challenge the Fed's outlook with rate cuts priced in for next year.

In company news, Kymera Therapeutics (NASDAQ: KYMR) has risen 14.6% after releasing positive data from a phase 1 trial of KT-474 for hidradenitis suppurativa and atopic dermatitis. In comparison, Delta Air Lines (NYSE: DAL) has increased by 2.8% after raising its Q4 revenue growth guidance.

It looks like Elon Musk's more unrestricted use of Twitter may conflict with new rules being introduced in the EU. Also, Musk sold $3.58 billion worth of Tesla (NASDAQ: TSLA) stock this week, but it's unclear what he plans to do with the money.

*Twitter (TWTR) is no longer publicly traded since Elon Musk took it private.

Dig a little deeper into the market update:

Check out our recent articles:

Is Kymera a Buy?

Who is Steve Wozniak?

Will The Black Rifle Coffee Stock Price Recover?

State of the ARKK: Should You Invest in ARK Innovation ETF?

Is Amazon Still a Good Investment?

Top LiDAR stocks to invest in

If you enjoyed this market update, why not check out our Daily Stock Watch analysis?

Share:

In this article:

Topics:
Capital Markets
Market Economy
Investing
Industries:
Financials
Information Technology
Healthcare
Companies:
Kymera Therapeutics
Tesla

Author: Kirsteen Mackay

This article does not provide any financial advice and is not a recommendation to deal in any securities or product. Investments may fall in value and an investor may lose some or all of their investment. Past performance is not an indicator of future performance.

Kirsteen Mackay does not hold any position in the stock(s) and/or financial instrument(s) mentioned in the above article.

Kirsteen Mackay has not been paid to produce this piece by the company or companies mentioned above.

Digitonic Ltd, the owner of ValueTheMarkets.com, does not hold a position or positions in the stock(s) and/or financial instrument(s) mentioned in the above article.

Digitonic Ltd, the owner of ValueTheMarkets.com, has not been paid for the production of this piece by the company or companies mentioned above.

Sign up for Investing Intel Newsletter